Sustained Remission of Generalized Lichen Planus Induced by Cyclophosphamide

Archives of Dermatology

Volumn 121, Issue 2, 1985, Pages 236-239

  Paslin, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMITRIPTYLINE; CYCLOPHOSPHAMIDE; DIPHENHYDRAMINE; EDETIC ACID; FLUOCINONIDE; GRISEOFULVIN; PREDNISONE; TRIAMCINOLONE ACETONIDE;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; CASE REPORT; DRUG THERAPY; HUMAN; LICHEN PLANUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THERAPY;

AGED; CASE REPORT; CYCLOPHOSPHAMIDE; FEMALE; HUMAN; LICHEN PLANUS; MALE; MIDDLE AGE;

EID: 0021954276     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1985.01660020094026     Document Type: Article

References (31)

1. Mann RJ, Wallington TB, Warin RP: Lichen planus with late onset hypogammaglobulinemia: A causal relationship? Br J Dermatol 1982;106 357-360.
2. Black MM: What is going on in lichen planus? Clin Exp Dermatol 1977;2 303-310.
3. Gomes MA, Schmitt DS, Souteyrand P, et al: Lichen planus and chronic graft-versus-host reaction: In situ identification of immunocompetent cell phenotypes. J Cutan Pathol 1982;9:249-257.
4. Bhan AK, Harrist TJ, Murphy GF, et al: T cell subsets and Langerhans cells in lichen planus: In situ characterization using monoclonal antibodies. Br J Dermatol 1981;105 617-622.
5. Sutton WT, Van Hagen F, Griffith BH, et al: Drug effects on survival of homografts of skins. Arch Surg 1963;87840-843.
6. Mufflins GM, Lenhard RE, Santos GW: Immunosuppressive effects of high dose cyclophosphamide therapy, abstracted. Proc Am Assoc Cancer Res 1973;14:63.
7. Robbins DS, Fudenberg HH: Human lymphocyte subpopulations in metastatic neoplasia: Six years later. N Engl J Med 1983;308 1595-1597.
8. Burg G, Rassner G, Braun-Falco O: Tierexperimentelle Untersuchungen uberden Einfluss von Cyclophosphamid (Endoxan) auf die akute und chronische Entzndung.Arch Klin Exp Dermatol 1969;23 661-71.
9. Turk JL, Poulter LW: Selective depletion of lymphoid tissue by cyclophosphamide. Clin Exp Immunol 1972;10 285-296.
10. Wheeler AG, Dansby D, Hawkins HC, et al: A toxicologic and hematologic evaluation of cyclophosphamide (Cytoxan) in experimental animals. Toxicol Appl Pharmacol 1962;4 324-343.
11. Carter PB, Bazin H: Immunology, in Baker HJ, Lindsey JR, Weisbroth SH (eds): The Laboratory Rat. New York, Academic Press Inc, 1980.
12. Cupps TR, Edgar LC, Fauci AS: Suppression of human B lymphocyte function by cyclophosphamide. J Immunol 1982; 128:2453-2457.
13. Aisenberg AC, David C: The thymus and recovery from cyclophosphamide-induced tolerance to sheep erythrocytes. J Exp Med 1968;12 835-46.
14. Bergsagel DE, Robertson GL, Hasselback R: Effect of cyclophosphamide on advanced lung cancer and the hematologic toxicity of large, intermittent intravenous doses. Can Med Assoc J 1968;98 532-538.
15. Schein PS, Winokur SH: Immunosuppressive and cytotoxic chemotherapy: Long-term complications. Ann Intern Med 1975; 82:84-95.
16. Spector JI, Zimbler H, Ross JS: Early-onset cyclophosphamide- induced interstitial pneumonitis. JAMA 1979;242 2852-2854.
17. Burke DA, Stoddart JC, Ward MK, et al: Fatal pulmonary fibrosis occurring during treatment with cyclophosphamide. Br Med J 1982;285:696.
18. Fairley KF, Barrie JU, Johnson W: Sterility and testicular atrophy related to cyclophosphamide therapy. Lancet 1972;1:568-569.
19. Uldall PR, Kerr DNS, Tacchi D: Sterility and cyclophosphamide. Lancet 1972;1693-694.
20. Johnson WW, Meadows DC: Urinary bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy. NEngl J Med 1971;284:290-294
21. Johnson WW, Meadows DC: Urinary bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy. NEngl J Med 1971;284 290-294.
22. Plotz PH, Klippel JH, Decker JL, et al: Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis. Ann Intern Med 1979; 91:221-223.
23. Baltus JAM, Boersma JW, Hartman AP, et al: The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: A controlled retrospective followup. Ann Rheum Dis 1983;42 368-373.
24. Ansher AF, Melton JW, Sliwinski AJ: Bladder malignancy in a patient receiving low dose cyclophosphamide for treatment of rheumatoid arthritis. Arthritis Rheum 1983;26 804-805.
25. Shah BC, Albert DJ: Intravesical instillation of formalin for the management of intractable hematuria. J Urol 1973;110:519-520.
26. Cyclophosphamide. IARC Monogr Eval Carcinog Risk Chem Hum 1981;26 165-202.
27. Hill DL: A Review of Cyclophosphamide. Springfield, Ill, Charles C Thomas Publisher, 1975.
28. Ortonne JP, Thivolet J, Sannwald C: Oral photochemotherapy in the treatment of lichen planus. Br J Dermatol 1978;99:77-88.
29. Vaatainen N, Hannuksela M, Karvonen J: Trioxsalen baths plus UV-A in the treatment of lichen planus and urticaria pigmentosa. Clin Exp Dermatol 1981;6 133-138.
30. Maidhof R: Zur systemischen Behandlung des oralen Lichen planus mit einem aromatischen Retinoid (Ro 10-9359). Z Hautkr 1979;54 873-876.
31. Snyder RA, Schwartz RA, Schneider JS, et al: Intermittent megadose corticosteroid therapy for generalized lichen planus. J Am Acad Dermatol 1982;6 1089-1090.